Omeros Corporation (OMER) Financials

OMER Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 286.8 million 338.2 million
March 31, 2026 286.2 million 349.5 million
Dec. 31, 2025 325.6 million 446.9 million
Sept. 30, 2025 185.7 million 406.2 million

OMER Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 4.1 million 1.6 million
March 31, 2026 -14.5 million 1.9 million
Dec. 31, 2025 -39.8 million 1.7 million
Sept. 30, 2025 -18.5 million 1.9 million

OMER Net Income

No data available :(

OMER Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 132.0 million 42.0 million 10.5 million
March 31, 2026 135.3 million 278.8 million 5.6 million
Dec. 31, 2025 171.8 million 208.5 million 13.5 million
Sept. 30, 2025 36.1 million 159.6 million 15.0 million

OMER Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 89.6 million
March 31, 2026 90.1 million
Dec. 31, 2025 63.5 million
Sept. 30, 2025 66.3 million

OMER Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 45000 13.8 million 13.9 million -
March 31, 2026 - 13.1 million 13.4 million -
Dec. 31, 2025 - 19.4 million 9.6 million -
Sept. 30, 2025 11000 16.0 million 10.4 million -

OMER Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 28.5 million 798000
March 31, 2026 9.9 million 826000
Dec. 31, 2025 - -
Sept. 30, 2025 - -

OMER

Price: $18.79

52 week price:
4.06
21.24

Earnings Per Share: 1.65 USD

P/E Ratio: 10.42

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 328300

Ebitda: -4.6 million

Market Capitalization: 1.3 billion

Links: